Skip to main content
Log in

Up-regulation of interleukin-2 mRNA in children with idiopathic nephrotic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

The current hypothesis for the pathogenesis of childhood idiopathic nephrotic syndrome (INS) favors the involvement of a T cell-mediated immune response. Various cytokines derived from T cells may play a critical role in INS. Previous studies have measured serum or urine cytokine levels and suggest an imbalance of the T cell-mediated immune response. To elucidate the true profile of T cell-derived cytokines, we determined interleukin (IL)-2, interferon (IFN)-γ, IL-4, IL-10, and tumor necrosis factor (TNF)-α mRNA expression in children with INS. We collected mRNA from peripheral blood mononuclear cells together with plasma and urine from nine children in the acute and remission phases of INS. Expression of IL-2, IFN-γ, IL-4, IL-10, and TNF-α mRNA was determined by a quantitative real-time PCR assay. Plasma and urine cytokine concentrations were measured using a specific enzyme-linked immunosorbent assay. These data were compared between the acute and remission phase in the same patients. The IL-2 mRNA levels were significantly higher in the acute phase than in the remission phase, whilst no significant difference was found in the other cytokines investigated. There was no significant difference in the plasma and urine cytokine concentrations between the acute and remission phase. Our results indicate increased expression of IL-2 mRNA in the acute phase of INS, suggesting that IL-2, at least in part, might be involved in the pathophysiology of childhood INS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Neuhaus TJ, Shah V, Callard RE, Barratt TM (1999) T-lymphocyte activation in steroid-sensitive nephrotic syndrome in childhood. Nephrol Dial Transplant 10:1348–1352

    Google Scholar 

  2. Cho BS, Yoon SR, Jang JY, Pyun KH, Lee CE (1999) Up-regulation of interleukin-4 and CD23/Fc epsilon RII in minimal change nephrotic syndrome. Pediatr Nephrol 13:199–204

    Article  CAS  PubMed  Google Scholar 

  3. Frank C, Herrmann M, Fernandez S, Dirnecker D, Boswald M, Kolowos W, Ruder H, Haas JP (2000) Dominant T cells in idiopathic nephrotic syndrome of childhood. Kidney Int 57:510–517

    Article  CAS  PubMed  Google Scholar 

  4. Daniel V, Trautmann Y, Konrad M, Nayir A, Scharer K (1997) T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol 47:289–297

    CAS  PubMed  Google Scholar 

  5. Stachowski J, Barth C, Michalkiewicz J, Krynicki T, Jarmolinski T, Runowski D, Lewandowska-Stachowiak M, Zaniew M, Warzywoda A, Bortkiewicz E, Dobosz M, Maciejewski J, Baldamus CA (2000) Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome. Pediatr Nephrol 14:779–785

    CAS  PubMed  Google Scholar 

  6. Lama G, Luongo I, Tirino G, Borriello A, Carangio C, Salsano ME (2002) T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis 39:958–965

    Article  CAS  PubMed  Google Scholar 

  7. Brodehl J (1991) The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies. Eur J Pediatr 150:380–387

    CAS  PubMed  Google Scholar 

  8. Melvin T, Bennett W (1991) Management of nephrotic syndrome in childhood. Drugs 42:30–51

    CAS  Google Scholar 

  9. Tejani A, Suthanthiran M, Pomrantz A (1991) A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children. Nephron 59:96–99

    CAS  PubMed  Google Scholar 

  10. Neuhaus TJ, Wadhwa M, Callard R, Barratt TM (1995) Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome. Clin Exp Immunol 100:475–479

    CAS  PubMed  Google Scholar 

  11. Stefanovic V, Golubovic E, Mitic-Zlatkovic M, Vlahovic P, Jovanovic O, Bogdanovic R (1998) Interleukin-12 and interferon-gamma production in childhood idiopathic nephrotic syndrome. Pediatr Nephrol 12:463–466

    Article  CAS  PubMed  Google Scholar 

  12. Matsumoto K, Kanmatsuse K (2001) Elevated interleukin-18 levels in the urine of nephrotic patients. Nephron 88:334–339

    Article  CAS  PubMed  Google Scholar 

  13. Bustos C, Gonzalez E, Muley R, Alonso JL, Egido J (1994) Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 24:799–805

    CAS  PubMed  Google Scholar 

  14. Hinoshita F, Noma T, Tomura S, Shiigai T, Yata J (1990) Decreased production and responsiveness of interleukin 2 in lymphocytes of patients with nephrotic syndrome. Nephron 54:122–126

    CAS  PubMed  Google Scholar 

  15. Suranyi MG, Guasch A, Hall BM, Myers BD (1993) Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis 21:251–259

    CAS  PubMed  Google Scholar 

  16. A report of the International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561–564

    PubMed  Google Scholar 

  17. Powrie F, Coffman RL (1993) Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 14:270–274

    Article  CAS  PubMed  Google Scholar 

  18. Romagnani S (1995) Biology of human TH1 and TH2 cells. J Clin Immunol 15:121–129

    CAS  PubMed  Google Scholar 

  19. Kunzendorf U, Tran TH, Bulfone-Paus S (1998) The Th1-Th2 paradigm in 1998: law of nature or rule with exceptions. Nephrol Dial Transplant 13:2445–2448

    Article  CAS  PubMed  Google Scholar 

  20. Laflam PF, Haraguchi S, Garin EH (2002) Cytokine mRNA profile in lipoid nephrosis: evidence for increased IL-8 mRNA stability. Nephron 91:620–626

    Article  CAS  PubMed  Google Scholar 

  21. Stordeur P, Poulin LF, Craciun L, Zhou L, Schandene L, Lavareille A de, Goriely S, Goldman M (2002) Cytokine mRNA quantification by real-time PCR. J Immunol Methods 259:55–64

    Article  CAS  PubMed  Google Scholar 

  22. Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC (1999) Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10:529–537

    CAS  PubMed  Google Scholar 

  23. Sahali D, Pawlak A, Valanciute A, Grimbert P, Lang P, Remy P, Bensman A, Guellen G (2002) A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 13:1238–1247

    CAS  PubMed  Google Scholar 

  24. Hirano T, Akashi T, Keira T, Oka K, Ihoya N, Yoshida (2000) Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome. Clin Pharmacol Ther 68:532–540

    Article  CAS  PubMed  Google Scholar 

  25. Briggs WA, Han SH, Miyakawa H, Burdick JF, Kwon HM (1999) Effects of glucocorticoids and cyclosporine on IL-2 and I kappa B alpha mRNA expression in human peripheral blood mononuclear cells. J Clin Pharmacol 39:119–124

    Article  CAS  PubMed  Google Scholar 

  26. Fujimoto S, Yamamoto Y, Hisanaga S, Yokota N, Eto T (1992) Recombinant interleukin-2 alone did not induce proteinuria with changes in anionic sites of the glomerular basement membrane in rats. Nephron 61:117–118

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mitsuru Nakajima.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimoyama, H., Nakajima, M., Naka, H. et al. Up-regulation of interleukin-2 mRNA in children with idiopathic nephrotic syndrome. Pediatr Nephrol 19, 1115–1121 (2004). https://doi.org/10.1007/s00467-004-1569-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-004-1569-y

Keywords

Navigation